News
Health Canada has allowed the firm to bypass a requirement that tests be authorized for non-professional use prior to self-test authorization.
Investigators compared risk prediction using PathomIQ's platform to molecular test results, evaluating its ability to predict biochemical recurrence in high-risk patients.
Last week, readers were most interested in a story about Diasorin's submission to FDA for its POC testing instrument.
The Tulane team has developed a handful of other assays for TB detection, including a mass spec test for paucibacillary TB ...
Broader macroeconomic uncertainty has resulted in continued cautiousness for both investors and acquirers in the in vitro ...
A lab owner, marketing firm owner, and doctor have been sentenced to between 13 months and five years in prison for their roles in a multimillion-dollar lab fraud scheme.
The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.
Lund, Sweden-based Qlucore aims to have bladder cancer and AML tests available for clinical use in Europe by 2027.
NEW YORK – After months of declining share prices, diagnostics firm got a reprieve in June as the 360 Top 30 rose nearly 6 percent month over month. The Top 30 mirrored the broader markets as the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results